BioCentury | Aug 15, 2018
Company News

Management tracks: Karuna, VBI Vaccines

...NASDAQ:VBIV) hired Christopher McNulty as CFO and head of business development. He was CFO at InVivo Therapeutics...
...Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Jaime De Leon Collegium Pharmaceutical Inc. Evolus Inc. EyePoint Pharmaceuticals Inc. Imara Inc. InVivo Therapeutics...
BioCentury | Jun 5, 2018
Company News

Management tracks: Sarepta, Gilead

...Inc. (South San Francisco, Calif.). Joseph was SVP, general counsel and chief compliance officer at InVivo Therapeutics...
BioCentury | Apr 1, 2017
Company News

Management tracks

...East and Asia at Aegerion Pharmaceuticals Inc., now Novelion Therapeutics Inc. (NASDAQ:NVLV; TSX:NVLV). Neurology company InVivo Therapeutics...
BioCentury | Jan 27, 2017
Company News

InVivo, PixarBio deal

...16 ). InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Cambridge, Mass. PixarBio Corp. (OTCQB:PXRB), Medford, Mass. Business: Neurology Chris Lieu InVivo Therapeutics...
BioCentury | Jan 13, 2017
Company News

InVivo, PixarBio deal

...deal. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Cambridge, Mass. PixarBio Corp. (OTCQB:PXRB), Medford, Mass. Business: Neurology Chris Lieu Neuro-spinal scaffold InVivo Therapeutics...
BioCentury | Aug 8, 2016
Financial News

Pain play PixarBio looks to raise up to $30M

...a professor at the Massachusetts Institute of Technology . The two also co-founded neurology company InVivo Therapeutics...
BioCentury | Apr 4, 2016
Finance

Fundamental reset

...LSE:HCM; NASDAQ:HCM) 3/17/16 $101.3 $1,627.6 $1,591.5 -2% InspireMD Inc. (NYSE-M:NSPR) 3/16/16 $1.1 $6.3 $5.4 -14% InVivo Therapeutics...
BioCentury | Mar 21, 2016
Financial News

InVivo Therapeutics completes follow-on

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Cambridge, Mass. Business: Neurology Date completed: 2016-03-15 Type: Follow-on Raised: $28 million Units: 3.7 million Price: $7.50 (unit) Shares after offering: 31.3 million Underwriters: Raymond James; Ladenburg Thalmann; Cantor Fitzgerald...
BioCentury | Jun 13, 2015
Company News

Management tracks

...head of clinical development at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), was most recently interim CMO at InVivo Therapeutics...
BioCentury | Feb 2, 2015
Financial News

InVivo Therapeutics completes direct public offering

InVivo Therapeutics Holdings Corp. (OTCQB:NVIV), Cambridge, Mass. Business: Neurology Date completed: 2015-01-29 Type: Direct public offering Raised: $12 million Shares: 8 million Price: $1.50 Shares after offering: 101.5 million Placement agent: H.C. Wainwright WIR Staff...
Items per page:
1 - 10 of 47
BioCentury | Aug 15, 2018
Company News

Management tracks: Karuna, VBI Vaccines

...NASDAQ:VBIV) hired Christopher McNulty as CFO and head of business development. He was CFO at InVivo Therapeutics...
...Sucampo Pharmaceuticals Inc., which Mallinckrodt plc (NYSE:MNK) acquired. Jaime De Leon Collegium Pharmaceutical Inc. Evolus Inc. EyePoint Pharmaceuticals Inc. Imara Inc. InVivo Therapeutics...
BioCentury | Jun 5, 2018
Company News

Management tracks: Sarepta, Gilead

...Inc. (South San Francisco, Calif.). Joseph was SVP, general counsel and chief compliance officer at InVivo Therapeutics...
BioCentury | Apr 1, 2017
Company News

Management tracks

...East and Asia at Aegerion Pharmaceuticals Inc., now Novelion Therapeutics Inc. (NASDAQ:NVLV; TSX:NVLV). Neurology company InVivo Therapeutics...
BioCentury | Jan 27, 2017
Company News

InVivo, PixarBio deal

...16 ). InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Cambridge, Mass. PixarBio Corp. (OTCQB:PXRB), Medford, Mass. Business: Neurology Chris Lieu InVivo Therapeutics...
BioCentury | Jan 13, 2017
Company News

InVivo, PixarBio deal

...deal. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Cambridge, Mass. PixarBio Corp. (OTCQB:PXRB), Medford, Mass. Business: Neurology Chris Lieu Neuro-spinal scaffold InVivo Therapeutics...
BioCentury | Aug 8, 2016
Financial News

Pain play PixarBio looks to raise up to $30M

...a professor at the Massachusetts Institute of Technology . The two also co-founded neurology company InVivo Therapeutics...
BioCentury | Apr 4, 2016
Finance

Fundamental reset

...LSE:HCM; NASDAQ:HCM) 3/17/16 $101.3 $1,627.6 $1,591.5 -2% InspireMD Inc. (NYSE-M:NSPR) 3/16/16 $1.1 $6.3 $5.4 -14% InVivo Therapeutics...
BioCentury | Mar 21, 2016
Financial News

InVivo Therapeutics completes follow-on

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV), Cambridge, Mass. Business: Neurology Date completed: 2016-03-15 Type: Follow-on Raised: $28 million Units: 3.7 million Price: $7.50 (unit) Shares after offering: 31.3 million Underwriters: Raymond James; Ladenburg Thalmann; Cantor Fitzgerald...
BioCentury | Jun 13, 2015
Company News

Management tracks

...head of clinical development at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), was most recently interim CMO at InVivo Therapeutics...
BioCentury | Feb 2, 2015
Financial News

InVivo Therapeutics completes direct public offering

InVivo Therapeutics Holdings Corp. (OTCQB:NVIV), Cambridge, Mass. Business: Neurology Date completed: 2015-01-29 Type: Direct public offering Raised: $12 million Shares: 8 million Price: $1.50 Shares after offering: 101.5 million Placement agent: H.C. Wainwright WIR Staff...
Items per page:
1 - 10 of 47